Is AtriCure Inc. (ATRC) Stock About to Get Hot Tuesday?

Overall market sentiment has been high on AtriCure Inc. (ATRC) stock lately. ATRC receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

AtriCure Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ATRC!

See Full ATRC Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With ATRC Stock Today?

AtriCure Inc. (ATRC) stock is trading at $40.14 as of 1:39 PM on Tuesday, Nov 14, a rise of $3.25, or 8.81% from the previous closing price of $36.89. The stock has traded between $38.20 and $40.23 so far today. Volume today is 302,792 compared to average volume of 378,488.

More About AtriCure Inc.

AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States. Click Here to get the full Stock Report for AtriCure Inc. stock.